Archived documents

Documents past their public comment period for Healthcare & Public Health.

FDAOther

M4Q(R2); The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality; Draft Guidance

19 comments

Net support +63% across analyzed comments

Top issues in comments

  • Content clarity and detail
  • Document organization and logic
  • Analytical procedure documentation
Read the record →Closes Mar 24
CMSNotice

Self-Attestation for Recertification of CORFs, OPT/SLP, and RHCs Providers and PXR Suppliers (CMS-10952A-D)

17 comments

Net support -88% across analyzed comments

Top issues in comments

  • Patient safety and oversight
  • Rhc survey and certification procedures
  • Reduced on-site survey frequency
Read the record →
FDAOther

Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry

17 comments

Net support +65% across analyzed comments

Top issues in comments

  • Impurity limits and control strategy
  • Terminology and definitions
  • Analytical method validation
Read the record →Closes Jun 23
CDCNotice

National Healthcare Safety Network (NHSN)

15 comments

Net support -7% across analyzed comments

Top issues in comments

  • Nhsn reporting definition accuracy
  • Burden of reporting
Read the record →Closes Jul 13
FDAOther

Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Draft Guidance for Industry

13 comments · 8 awaiting analysis

Net support +40% across analyzed comments

Top issues in comments

Not yet determined
Read the record →Closes Dec 22
VANPRM

Expanding Access to State Prescription Drug Monitoring Programs (AS73)

11 comments

Net support +36% across analyzed comments

Top issues in comments

  • Immigration enforcement fee amount
Read the record →
CDCRule

Control of Communicable Diseases; Foreign Quarantine

8 comments

Net support -50% across analyzed comments

Top issues in comments

  • Travel restrictions effectiveness
  • Equitable public health policies
  • Public health evidence
Read the record →
FDAOther

Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment; Guidance for Industry; Draft Guidance

7 comments · 7 awaiting analysis

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 20
FDAOther

Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-inHuman (FIH) Trials; Guidance for Industry; Draft Guidance

6 comments · 5 awaiting analysis

Net support 0% across analyzed comments

Top issues in comments

Not yet determined
Read the record →Closes Jul 25
CDCNotice

Extended Evaluation of the National Tobacco Prevention and Control Public Education Campaign 2026-07761

6 comments

Net support +100% across analyzed comments

Top issues in comments

  • Support for campaign evaluation
Read the record →
CDCNotice

Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists

5 comments

Net support -100% across analyzed comments

Top issues in comments

  • Agency jurisdiction and expertise
  • Lpr travel status
Read the record →
CMSProposed Rule

CY 2027 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates. CMS-1850-P Display

5 comments

Net support -60% across analyzed comments

Top issues in comments

  • Asc reimbursement rates
  • Device-intensive designation
  • Missing records as mismatches
Read the record →